226 related articles for article (PubMed ID: 22587019)
1. Amino acid metabolism related to immune tolerance by MDSCs.
Yang B; Wang X; Ren X
Int Rev Immunol; 2012 Jun; 31(3):177-83. PubMed ID: 22587019
[TBL] [Abstract][Full Text] [Related]
2. Antigen specificity of immune suppression by myeloid-derived suppressor cells.
Solito S; Bronte V; Mandruzzato S
J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
4. T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress.
Rodríguez PC; Ochoa AC
Semin Cancer Biol; 2006 Feb; 16(1):66-72. PubMed ID: 16298138
[No Abstract] [Full Text] [Related]
5. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
Fujimura T; Mahnke K; Enk AH
J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
[TBL] [Abstract][Full Text] [Related]
6. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs.
Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY
J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024
[TBL] [Abstract][Full Text] [Related]
7. Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells.
Singh V; Mueller U; Freyschmidt-Paul P; Zöller M
Eur J Immunol; 2011 Oct; 41(10):2871-82. PubMed ID: 21728175
[TBL] [Abstract][Full Text] [Related]
8. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression.
Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R
J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238
[TBL] [Abstract][Full Text] [Related]
9. Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.
Pinton L; Solito S; Damuzzo V; Francescato S; Pozzuoli A; Berizzi A; Mocellin S; Rossi CR; Bronte V; Mandruzzato S
Oncotarget; 2016 Jan; 7(2):1168-84. PubMed ID: 26700461
[TBL] [Abstract][Full Text] [Related]
10. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
[TBL] [Abstract][Full Text] [Related]
11. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy.
Tadmor T; Attias D; Polliack A
Br J Haematol; 2011 Jun; 153(5):557-67. PubMed ID: 21477210
[TBL] [Abstract][Full Text] [Related]
13. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.
Haile LA; Gamrekelashvili J; Manns MP; Korangy F; Greten TF
J Immunol; 2010 Jul; 185(1):203-10. PubMed ID: 20525890
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-derived suppressor cell role in tumor-related inflammation.
Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
[TBL] [Abstract][Full Text] [Related]
16. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
Ye XZ; Yu SC; Bian XW
J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
[TBL] [Abstract][Full Text] [Related]
17. The immunosuppressive activity of MDSCs requires expression of CHOP.
Cancer Discov; 2014 Nov; 4(11):1254. PubMed ID: 25367942
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cells as regulators of the immune system.
Gabrilovich DI; Nagaraj S
Nat Rev Immunol; 2009 Mar; 9(3):162-74. PubMed ID: 19197294
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells help protective immunity to Leishmania major infection despite suppressed T cell responses.
Pereira WF; Ribeiro-Gomes FL; Guillermo LV; Vellozo NS; Montalvão F; Dosreis GA; Lopes MF
J Leukoc Biol; 2011 Dec; 90(6):1191-7. PubMed ID: 21934068
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
